Item 16. FORM 10-K SUMMARY
4K characters. Original on sec.gov · Markdown
Item 16. FORM 10-K SUMMARY
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| GILEAD SCIENCES, INC. | |||||
| By: | /s/ DANIEL P. O’DAY | ||||
| Daniel P. O’Day Chairman and Chief Executive Officer | |||||
| Date: | February 24, 2026 |
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Daniel P. O’Day and Keeley M. Cain Wettan, and each of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place, and stead, in any and all capacities, to sign any and all amendments to this Report, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming that all said attorneys-in-fact and agents, or any of them or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date | ||||||||||||
| /s/ DANIEL P. O’DAY | Chairman and Chief Executive Officer | February 24, 2026 | ||||||||||||
| Daniel P. O’Day | (Principal Executive Officer) | |||||||||||||
| /s/ ANDREW D. DICKINSON | Chief Financial Officer | February 24, 2026 | ||||||||||||
| Andrew D. Dickinson | (Principal Financial Officer) | |||||||||||||
| /s/ ERIN E. BURKHART | Senior Vice President, Controllership and Chief Accounting Officer | February 24, 2026 | ||||||||||||
| Erin E. Burkhart | (Principal Accounting Officer) | |||||||||||||
| /s/ JACQUELINE K. BARTON | Director | February 24, 2026 | ||||||||||||
| Jacqueline K. Barton, Ph.D. | ||||||||||||||
| /s/ JEFFREY A. BLUESTONE | Director | February 24, 2026 | ||||||||||||
| Jeffrey A. Bluestone, Ph.D. | ||||||||||||||
| /s/ SANDRA J. HORNING | Director | February 24, 2026 | ||||||||||||
| Sandra J. Horning, M.D. | ||||||||||||||
| /s/ KELLY A. KRAMER | Director | February 24, 2026 | ||||||||||||
| Kelly A. Kramer | ||||||||||||||
| /s/ TED W. LOVE | Director | February 24, 2026 | ||||||||||||
| Ted W. Love, M.D. | ||||||||||||||
| /s/ HARISH MANWANI | Director | February 24, 2026 | ||||||||||||
| Harish Manwani | ||||||||||||||
| /s/ JAVIER J. RODRIGUEZ | Director | February 24, 2026 | ||||||||||||
| Javier J. Rodriguez | ||||||||||||||
| /s/ ANTHONY WELTERS | Director | February 24, 2026 | ||||||||||||
| Anthony Welters |
Previous: Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES